Further data to address the Alzheimer's coverage with evidence development questions

Malaz Boustani, Eric G Klein, Jennifer A Zimmer, Hong Wang, Staci E Engle, Adam Phipps, Maureen Japha, Traci Schilling, Ann Hartry, for the Alzheimer's Disease Neuroimaging Initiative · 2026

Read Further data to address the Alzheimer's coverage with evidence development questions by Malaz Boustani, Eric G Klein, Jennifer A Zimmer, Hong Wang, Staci E Engle, Adam Phipps, Maureen Japha, Traci Schilling, Ann Hartry, for the Alzheimer's Disease Neuroimaging Initiative (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13438179.txt.

Description

Boustani and colleagues, writing for the Alzheimer's Disease Neuroimaging Initiative, update the evidence behind Medicare's coverage rules for amyloid-targeting Alzheimer's drugs in this 2026 paper. Since 2022, Medicare has covered these drugs only under coverage with evidence development. That policy requires further proof. A 2024 review addressed the regulator's stated questions. This update adds extension data for donanemab and lecanemab and newer safety findings.

The extension studies show the treatment benefit continuing to build over time, with no new safety signals appearing during the longer follow-up periods covered. Safety analyses identified baseline traits that raise the risk of amyloid-related imaging abnormalities, the brain swelling or bleeding side effects of these drugs. A slower dose-escalation schedule for donanemab lowered the risk of the swelling type, and the authors argue the evidence now justifies reconsidering the coverage policy.

Catalog record

CREATORMalaz Boustani, Eric G Klein, Jennifer A Zimmer, Hong Wang, Staci E Engle, Adam Phipps, Maureen Japha, Traci Schilling, Ann Hartry, for the Alzheimer's Disease Neuroimaging Initiative
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13438179

Browse the full library · About the Tower of Babel